newsfilter
← Latest News
Business Wire·

MyMD Pharmaceuticals Receives FDA IND Clearance to Begin Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan

Believed to be the only IND application ever cleared by the FDA for a Phase 2 trial of a patented drug for delaying aging Phase 2 trial recruiting begins immediately; efficacy data expected by the end of the first quarter of 2022 MyMD Pharmaceutic